Mylan to Offer Some Patients Aid on Cost of EpiPens

Responding to a growing furor from consumers and politicians, the pharmaceutical company Mylan said on Thursday that it would lower the out-of-pocket costs to some patients who need EpiPens, which are used to treat life-threatening allergy attacks.